Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Blood Pressure and Hypertension Studies, Hormonal Regulation and Hypertension, Renin-Angiotensin System Studies, and Sodium Intake and Health.
The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in Hypertension
Citrate‐Dependent Activation of Acetyl
<scp>CoA</scp>
Carboxylase Promotes Renal Lipid Accumulation in a Rat Model of Chronic Kidney Disease
Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement.
Beyond the RAAS: The Search for Novel Antihypertensive Therapies: A Needle in the Haystack?
The Role of β-Blockers in the Evolving Treatment Landscape of Resistant Hypertension.
The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in Hypertension.
Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control study
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)
Lowering of systolic blood pressure with ESPRIT along the BPROAD: the lower the better?
Management of 'Elevated' blood pressure according to the 2024 European Society of Cardiology Guidelines: lack of supportive evidence and high risk of excessive treatment.
Patient perceptions, motivations and barriers to treatment adherence in hypertension: results of a questionnaire-based survey in five European countries.
Better blood pressure control with predictable drug dosing
Calcium channel blockers and mental health: a comprehensive meta-analysis of psychiatric adverse events in double-blind randomized controlled trials
2024 European Society of Hypertension MASTERplan for the management of arterial hypertension
Long-term Intake of Statins or Renin-Angiotensin-System Inhibitors and Their Association With Parameters of Sarcopenia in Older Persons
Prime Time for (im) Precision Medicine: From Randomized Clinical Trials to Real-World Evidence.
CTRH as Biomarker of Drug Efficacy: In-Depth Assessment of Real-World Evidence.
2024 European Society of Hypertension MASTERplan for the management of arterial hypertension.
Non-debatable issues in defining blood pressure targets for hypertension - Editorial.
The nuclear export inhibitor selinexor improves kidney function in a rat model of focal segmental glomerulosclerosis.
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension.
Understanding the impact of alcohol on blood pressure and hypertension: From moderate to excessive drinking
Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.
Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines.
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence.
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study)